FDA Approves Mepolizumab for COPD
MedPage Today) — The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday. Labeling for the interleukin-5 (IL-5) antagonist stipulates use…
MedPage Today) — The FDA approved mepolizumab (Nucala) for adults with inadequately controlled chronic obstructive pulmonary disease (COPD), drugmaker GSK announced on Thursday.
Labeling for the interleukin-5 (IL-5) antagonist stipulates use…
Read More